The Day In Review: Biotech Drops Back While Individual Issues Shine

The market moved lower for most of the day on Tuesday, taking biotech with it. The Centient Biotech 200 lost 23.92 to 3379.10, a loss of .7%, while the NYSE Composite dropped .38%, and Nasdaq was lower by .48%. We cover what happened to Transgene, Mylan, King, Pfizer, Novartis and CoTherix.

Back to news